Adaptive Biotechnologies Corp (NASDAQ: ADPT) is a leading biotechnology company focusing on immune-driven medicine.Julie Rubinstein, President and COO, executed a series of stock sales in March 2026, significantly reducing her holdings.Despite challenges in profitability, ADPT shows financial stability with a strong current ratio and a moderate level of debt.Adaptive Biotechnologies Corp (NASDAQ: ADPT) is a biotechnology company that focuses on the development of immune-driven medicine. The company leverage ...